The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau-Reference-Cited by-同舟云学术

The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau

Published:2021-03-31 Issue:9 Volume:17 Page:1575-1582
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hansson Oskar¹²,Batrla Richard³,Brix Britta⁴,Carrillo Maria C.⁵,Corradini Veronika⁶,Edelmayer Rebecca M.⁵,Esquivel Rianne N.⁷,Hall Christina⁸,Lawson John⁷,Bastard Nathalie Le⁹,Molinuevo José Luis¹⁰¹¹,Nisenbaum Laura K.¹²,Rutz Sandra¹³,Salamone Salvatore J.¹⁴,Teunissen Charlotte E.¹⁵,Traynham Christopher⁷,Umek Robert M.¹⁶,Vanderstichele Hugo¹⁷,Vandijck Manu⁹,Wahl Simone¹⁴,Weber Christopher J.⁵,Zetterberg Henrik¹⁸¹⁹²⁰²¹,Blennow Kaj¹⁸¹⁹

Affiliation:

1. Clinical Memory Research Unit, Department of Clinical Sciences Malmö Lund University Lund Sweden

2. Memory Clinic Skåne University Hospital Malmö Sweden

3. Novartis Pharmaceuticals Basel Switzerland

4. EUROIMMUN AG Lübeck Germany

5. Alzheimer's Association Chicago Illinois USA

6. Roche Diagnostics International Rotkreuz Switzerland

7. Fujirebio Diagnostics Inc Malvern Pennsylvania USA

8. Fujirebio Diagnostics AB Göteborg Sweden

9. Fujirebio Europe NV Ghent Belgium

10. BarcelonaBeta Brain Research Center Pasqual Maragall Foundation Barcelona Barcelona Spain

11. AD and Other Cognitive Disorders Unit Hospital Clinic Barcelona Spain

12. Biogen Cambridge Massachusetts USA

13. Roche Diagnostics GmbH Penzberg Germany

14. Saladax Biomedical Inc. Bethlehem Bethlehem Pennsylvania USA

15. Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam the Netherlands

16. Meso Scale Diagnostics Rockville Maryland USA

17. Biomarkable bv Consulting Ghent Belgium

18. Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology the Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

19. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

20. Department of Neurodegenerative Disease UCL Institute of Neurology, Queen Square London UK

21. UK Dementia Research Institute at UCL London UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12316

Reference60 articles.

1. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of LC–MS/MS in clinical laboratories;Clinica Chimica Acta;2024-03

2. Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers;Alzheimer's & Dementia;2024-01-30

3. Contributions of amyloid beta and cerebral small vessel disease in clinical decline;Alzheimer's & Dementia;2023-12-25

4. Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum;International Journal of Molecular Sciences;2023-12-11

5. Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer’s disease pathogenesis;Brain;2023-12-10